'Hibernating' myocardium: Asleep or part dead?

Journal of the American College of Cardiology

Volumn 28, Issue 2, 1996, Pages 530-535

  Armstrong, William F ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL VIABILITY; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CORONARY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY; HEART; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030220731     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00138-6     Document Type: Review

References (43)

1. 1. Weiner JM, Apstein CS, Arthur JH, Pirzada FA, Hood WF Jr. Persistence of myocardial injury following brief periods of coronary occlusion. Cardiovasc Res 1976;10:678-86.
2. 2. Heyndrickx GR, Baig H, Nellens P, Leusen I, Fishbein MC, Vatner SF. Depression of regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol 1978;234:H653-9.
3. 3. Matsuzaki M, Gallagher KP, Kemper WS, White F, Ross J. Sustained regional dysfunction produced by prolonged coronary stenosis: gradual recovery after reperfusion. Circulation 1983;68:170-82.
4. 4. Mercier JC, Lando U, Kanmatsuse K, et al. Divergent effects of inotropic stimulation on the ischemic and severely depressed reperfused myocardium. Circulation 1982;66:397-400.
5. 5. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
6. 6. Broderick TM, Bourdillon PDV, Ryan T, Feigenbaum H, Dillon JC, Armstrong WF. Comparison of regional and global left ventricular function by serial echocardiograms after reperfusion in acute myocardial infarction. J Am Soc Echocardiogr 1989;2:315-23.
7. 7. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72 Suppl V:V-123-35.
8. 8. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
9. 9. Vanoverschelde JLJ, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans. Circulation 1993;87:1513-23.
10. 10. Marban E. Myocardial stunning and hibernation. The physiology behind the colloquialisms. Circulation 1991;83:681-8.
11. 11. Neely JR, Grotyohann LW. Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine and triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res 1984;55:816-24.
12. 12. Dyke SH, Cohn PF, Gorlin R, Sonnenblick EH. Detection of residual myocardial function in coronary artery disease using post-extra systolic potentiation. Circulation 1974;49:1063-71.
13. 201TI imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
14. 14. Sabia PJ, Powers ER, Ragosta M, Smith WH, Watson DD, Kaul S. Role of quantitative planar thallium-201 imaging for determining viability in patients with acute myocardial infarction and a totally occluded infarct-related artery. J Nucl Med 1993;34:728-36.
15. 15. Dilsizian V, Freedman NMT, Bacharach SL, Perrone-Filardi P, Bonow RO. Regional thallium uptake in irreversible defects. Circulation 1992;85:627-34.
16. 16. Charney R, Schwinger ME, Chun J, et al. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J 1994;128:864-9.
17. 17. Tillisch JG, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
18. 18. Schelbert HR, Phelps ME, Hoffman E, Huang SC, Kuhl DE. Regional myocardial blood flow, metabolism, and function assessed noninvasively with positron emission tomography. Am J Cardiol 1980;46:1269-77.
19. 19. Piérard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15: 1021-31.
20. 20. Barilla F, Gheorghiade M, Alam M, Khaja F, Golstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-31.
21. 21. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
22. 22. Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.
23. 23. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Circulation 1995;91:663-70.
24. 24. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26.
25. 25. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine. Circulation 1995;91:990-8.
26. 26. Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995; 91:2556-65.
27. 27. Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization. Circulation 1995;91:2748-52.
28. 18F] fluorodeoxyglucose in patients with chronic coronary artery disease. Circulation 1995;91:1006-15.
29. 29. Vanoverschelde JLJ, Gerber BL, D'Hondt A, et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization. Circulation 1995;92 Suppl II:II-37-44.
30. 30. lto H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. Circulation 1991;85:1699-705.
31. 31. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992;327:1825-31.
32. 32. DeFilippi CR, Willett DL, Irani WN, Eichhorn EJ, Velasco CE, Grayburn PA. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995;92:2863-8.
33. 33. Lewis SJ, Sawada SG, Ryan T, Segar DS, Armstrong WF, Feigenbaum H. Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium. Am Heart J 1991;121:1088-94.
34. 34. Eitzman D, Al-Aouar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
35. 35. Di Carli DF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
36. 36. Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-44.
37. 37. Lieberman AN, Weiss JL, Jugdutt BI, et al. Relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation 1981;63:739-46.
38. 38. Weintraub WS, Hattori S, Agarwal JB, Bodenheimer MM, Banka VS, Helfant RH. The relationship between myocardial blood flow and contraction by myocardial layer in the canine left ventricle during ischemia. Circ Res 1981;48:430-8.
39. 39. Myers JH, Stirling MC, Choy M, Buda AJ, Gallagher KP. Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography. Circulation 1986;74:164-72.
40. 40. Homans DC, Pavek T, Laxson DD, Bache RJ. Recovery of transmural and subepicardial wall thickening after subendocardial infarction. J Am Coll Cardiol 1994;24:1109-16.
41. 41. Sklenar J, Ismail S, Villanueva FS, Goodman C, Glasheen WP, Kaul S. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion. Circulation 1994;90:1502-12.
42. 42. Mertes H, Segar DS, Johnson M, Ryan T, Sawada SG, Feigenbaum H. Assessment of hibernating myocardium by dobutamine stimulation in a canine model. J Am Coll Cardiol 1995;26:1348-55.
43. 43. Chen C, Li L, Long Chen L, et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation 1995;92:756-66.